Serratia marcescens as a postoperative pathogen.
D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D002228:Carbenicillin / Q000627:therapeutic use; D002512:Cephalothin / Q000627:therapeutic use; D002701:Chloramphenicol / Q000494:pharmacology / Q000627:therapeutic use; D004697:Endocarditis, Bacterial / Q000188:drug therapy; D004756:Enterobacteriaceae Infections / Q000188:drug therapy / Q000209:etiology* / Q000517:prevention & control; D005839:Gentamicins / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007612:Kanamycin / Q000627:therapeutic use; D008826:Microbial Sensitivity Tests; D009268:Nalidixic Acid / Q000494:pharmacology / Q000627:therapeutic use; D010118:Oxytetracycline / Q000627:therapeutic use; D010403:Penicillin Resistance; D011113:Polymyxins / Q000627:therapeutic use; D018805:Sepsis / Q000209:etiology / Q000628:therapy; D012706:Serratia marcescens / Q000187:drug effects / Q000302:isolation & purification / Q000472:pathogenicity*; D013530:Surgical Wound Infection / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D014552:Urinary Tract Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D011113:Polymyxins; D009268:Nalidixic Acid; D007612:Kanamycin; D002701:Chloramphenicol; D000667:Ampicillin; D002228:Carbenicillin; D002512:Cephalothin; D010118:Oxytetracycline